These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11847201)

  • 1. Phorbol diacetate potentiates na(+)-k(+) ATPase inhibition by a putative endogenous ligand, marinobufagenin.
    Fedorova OV; Dorofeeva NA; Lopatin DA; Lakatta EG; Bagrov AY
    Hypertension; 2002 Feb; 39(2):298-302. PubMed ID: 11847201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV; Bagrov AY
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus.
    Bagrov YY; Manusova NB; Egorova IA; Fedorova OV; Bagrov AY
    Front Biosci; 2005 Sep; 10():2257-62. PubMed ID: 15970492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    J Hypertens; 2004 Feb; 22(2):389-97. PubMed ID: 15076199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump.
    Fedorova OV; Kashkin VA; Zakharova IO; Lakatta EG; Bagrov AY
    J Hypertens; 2012 Sep; 30(9):1817-26. PubMed ID: 22796708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The α2 isoform Na,K-ATPase modulates contraction of rat mesenteric small artery via cSrc-dependent Ca
    Bouzinova EV; Hangaard L; Staehr C; Mazur A; Ferreira A; Chibalin AV; Sandow SL; Xie Z; Aalkjaer C; Matchkov VV
    Acta Physiol (Oxf); 2018 Sep; 224(1):e13059. PubMed ID: 29480968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of Na+/K+-ATPase isoform distribution in rat ventricular myocytes.
    Despa S; Bers DM
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C321-7. PubMed ID: 17392375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.
    Wansapura AN; Lasko V; Xie Z; Fedorova OV; Bagrov AY; Lingrel JB; Lorenz JN
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1833-9. PubMed ID: 19376809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
    Bagrov AY; Roukoyatkina NI; Pinaev AG; Dmitrieva RI; Fedorova OV
    Eur J Pharmacol; 1995 Feb; 274(1-3):151-8. PubMed ID: 7768267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY; Dmitrieva RI; Fedorova OV; Kazakov GP; Roukoyatkina NI; Shpen VM
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cardiotonic steroids on isolated perfused kidney and NHE3 activity in renal proximal tubules.
    Godinho AN; Costa GT; Oliveira NO; Cardi BA; Uchoa DEA; Silveira ER; Quintas LEM; Noël FG; Fonteles MC; Carvalho KM; Santos CF; Lessa LMA; do Nascimento NRF
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1943-1950. PubMed ID: 28506883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
    Fedorova OV; Anderson DE; Bagrov AY
    Am J Hypertens; 1998 Jul; 11(7):796-802. PubMed ID: 9683040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective ligands for Na
    Chakraborty D; Fedorova OV; Bagrov AY; Kaphzan H
    Neuropharmacology; 2017 May; 117():338-351. PubMed ID: 28232062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.